Impact of Home Confinement During the COVID-19 Pandemic on Medication Use and Disease Activity in Spondyloarthritis Patients.
作者信息
Roux C H, Brocq O, Gerald F, Pradier C, Bailly L
机构信息
University Hospital Centre Nice and Cote d'Azur University, Nice, France.
Princess Grace Hospital, Monaco.
出版信息
Arthritis Rheumatol. 2020 Oct;72(10):1771-1772. doi: 10.1002/art.41397. Epub 2020 Sep 6.
Abstract
摘要
相似文献
1
Impact of Home Confinement During the COVID-19 Pandemic on Medication Use and Disease Activity in Spondyloarthritis Patients.新冠疫情期间居家隔离对脊柱关节炎患者用药及疾病活动的影响
Arthritis Rheumatol. 2020 Oct;72(10):1771-1772. doi: 10.1002/art.41397. Epub 2020 Sep 6.
2
Clinical impact of COVID-19 on a French population of spondyloarthritis patients.
Clin Rheumatol. 2020 Nov;39(11):3185-3187. doi: 10.1007/s10067-020-05413-9. Epub 2020 Sep 24.
3
Navigating the complexities of difficult-to-treat axial spondyloarthritis.应对难治性中轴型脊柱关节炎的复杂性。
Joint Bone Spine. 2024 Sep;91(5):105770. doi: 10.1016/j.jbspin.2024.105770. Epub 2024 Aug 6.
4
Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?脊柱关节炎：甲氨蝶呤对银屑病关节炎有效吗？
Nat Rev Rheumatol. 2012 May 2;8(5):251-2. doi: 10.1038/nrrheum.2012.56.
5
Three months treatment of active spondyloarthritis with imatinib mesylate: an open-label pilot study with six patients.
Rheumatology (Oxford). 2006 Dec;45(12):1573-5. doi: 10.1093/rheumatology/kel365. Epub 2006 Oct 31.
6
[Psoriatic arthritis and general recommendations for targeted therapy of spondyloarthritis].
Dtsch Med Wochenschr. 2013 Oct;138(40):2037-40. doi: 10.1055/s-0033-1349573. Epub 2013 Sep 24.
7
The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis.脊柱关节炎的当前概念，特别强调未分化脊柱关节炎。
Rheumatology (Oxford). 2005 Dec;44(12):1483-91. doi: 10.1093/rheumatology/kei047. Epub 2005 Aug 9.
8
Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study.生物制剂治疗脊柱关节炎的感染复发：一项单中心研究。
Scand J Rheumatol. 2012;41(6):490-1. doi: 10.3109/03009742.2012.698393. Epub 2012 Sep 18.
9
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].[德国风湿病学会关于包括贝赫切特病和早期形式的轴性脊柱关节炎的S3指南：8.4药物治疗，8.5药物治疗措施的疗效评估]
Z Rheumatol. 2014 Sep;73 Suppl 2:78-96. doi: 10.1007/s00393-014-1443-7.
10
Impact of ACR 2010 fibromyalgia criteria fulfillment on disease activity evaluation in patients with axial spondyloarthritis treated with infliximab.2010年美国风湿病学会纤维肌痛标准的满足情况对接受英夫利昔单抗治疗的中轴型脊柱关节炎患者疾病活动度评估的影响
Joint Bone Spine. 2019 Jan;86(1):113-114. doi: 10.1016/j.jbspin.2018.04.001. Epub 2018 Apr 20.
引用本文的文献
1
The Calm after the Storm: A State-of-the-Art Review about Recommendations Put Forward during the COVID-19 Pandemic to Improve Chronic Pain Management.风暴后的平静：关于新冠疫情期间为改善慢性疼痛管理而提出的建议的最新综述
J Clin Med. 2023 Nov 22;12(23):7233. doi: 10.3390/jcm12237233.
2
Impact of COVID-19 Pandemic on Patients with Rheumatic and Musculoskeletal Diseases: Disruptions in Care and Self-Reported Outcomes.2019年冠状病毒病大流行对风湿性和肌肉骨骼疾病患者的影响：护理中断和自我报告的结果
J Patient Exp. 2022 May 23;9:23743735221102678. doi: 10.1177/23743735221102678. eCollection 2022.
3
Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1).新冠疫情及封锁期间中轴型脊柱关节炎患者的健康状况不佳及功能受限：REUMAVID研究（第1阶段）
Ther Adv Musculoskelet Dis. 2022 Jan 19;14:1759720X211066685. doi: 10.1177/1759720X211066685. eCollection 2022.
4
Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1).COVID-19防控措施对英国和欧洲风湿性和肌肉骨骼疾病患者的影响：REUMAVID研究（第一阶段）
Rheumatol Adv Pract. 2021 Dec 4;5(3):rkab098. doi: 10.1093/rap/rkab098. eCollection 2021.
5
The overall impact of COVID-19 on healthcare during the pandemic: A multidisciplinary point of view.新冠疫情期间COVID-19对医疗保健的总体影响：多学科视角
Health Sci Rep. 2021 Oct 1;4(4):e386. doi: 10.1002/hsr2.386. eCollection 2021 Dec.
6
Rapid Review of Medication Taking (Adherence) Among Patients With Rheumatic Diseases During the COVID-19 Pandemic.COVID-19 大流行期间风湿性疾病患者的药物（依从性）服用快速回顾。
Arthritis Care Res (Hoboken). 2022 Dec;74(12):1961-1969. doi: 10.1002/acr.24744. Epub 2022 Aug 22.
7
[Not Available].[无可用内容]。
Rev Rhum Ed Fr. 2021 Oct;88(5):326-328. doi: 10.1016/j.rhum.2021.03.007. Epub 2021 Apr 2.
8
Can SARS-CoV-2 trigger reactive arthritis?新型冠状病毒能引发反应性关节炎吗？
Joint Bone Spine. 2021 Jan;88(1):105086. doi: 10.1016/j.jbspin.2020.105086. Epub 2020 Oct 27.
本文引用的文献
1
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.美国风湿病学会在 COVID-19 大流行期间成人患者风湿性疾病管理指南：第 1 版。
Arthritis Rheumatol. 2020 Aug;72(8):1241-1251. doi: 10.1002/art.41301. Epub 2020 Jun 5.
2
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?新型冠状病毒肺炎与非甾体抗炎药和皮质类固醇治疗：我们是否应在临床环境中限制其使用？
Ecancermedicalscience. 2020 Mar 30;14:1023. doi: 10.3332/ecancer.2020.1023. eCollection 2020.
3
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.一系列接受免疫抑制靶向治疗的慢性关节炎患者的 COVID-19 临床病程。
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
4
Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA): results from BSRBR-AS.预测接受抗 TNF-α 治疗的中轴型脊柱关节炎（axSpA）患者的反应：BSRBR-AS 的结果。
Rheumatology (Oxford). 2020 Sep 1;59(9):2481-2490. doi: 10.1093/rheumatology/kez657.
5
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.2019 年美国风湿病学会/脊柱关节炎协会/脊柱关节炎研究和治疗网络关于治疗强直性脊柱炎和非放射学中轴型脊柱关节炎的建议更新。
Arthritis Rheumatol. 2019 Oct;71(10):1599-1613. doi: 10.1002/art.41042. Epub 2019 Aug 22.
6
Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.抗 TNF 治疗在脊柱关节炎及相关疾病中的应用，对免疫系统的影响及治疗反应预测。
Front Immunol. 2019 Mar 19;10:382. doi: 10.3389/fimmu.2019.00382. eCollection 2019.
7
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.2016 年更新的 ASAS-EULAR 中轴型脊柱关节炎管理推荐。
Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13.
8
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.类风湿关节炎、银屑病关节炎和强直性脊柱炎中使用抗TNF药物的感染风险：一项系统评价和荟萃分析。
Expert Opin Drug Saf. 2016 Dec;15(sup1):11-34. doi: 10.1080/14740338.2016.1240783.
9
Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study.高强度运动对活动期轴向性脊柱关节炎疾病活动度及心血管风险的疗效：一项随机对照试验性研究
PLoS One. 2014 Sep 30;9(9):e108688. doi: 10.1371/journal.pone.0108688. eCollection 2014.
Zotero 插件